Trial Outcomes & Findings for Eye Gaze Guidance Evaluation in Phantoms (NCT NCT07174479)
NCT ID: NCT07174479
Last Updated: 2026-05-22
Results Overview
Percentage of kidney that was visualized
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
10 participants
Primary outcome timeframe
up to 24 hours after the study was completed by the participant
Results posted on
2026-05-22
Participant Flow
Participant milestones
| Measure |
AR Guided
Trainees can see experts' gaze through the HoloLens
|
Non-AR Guided
Trainees cannot see experts' gaze through the HoloLens. This should be the standard of care control group.
|
|---|---|---|
|
Overall Study
STARTED
|
5
|
5
|
|
Overall Study
COMPLETED
|
5
|
5
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Eye Gaze Guidance Evaluation in Phantoms
Baseline characteristics by cohort
| Measure |
AR Guided
n=5 Participants
Trainees can see experts' gaze through the HoloLens
|
Non-AR Guided
n=5 Participants
Trainees cannot see experts' gaze through the HoloLens. This should be the standard of care control group.
|
Total
n=10 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
30 years
n=2 Participants
|
31 years
n=4 Participants
|
31 years
n=6 Participants
|
|
Sex: Female, Male
Female
|
3 Participants
n=2 Participants
|
2 Participants
n=4 Participants
|
5 Participants
n=6 Participants
|
|
Sex: Female, Male
Male
|
2 Participants
n=2 Participants
|
3 Participants
n=4 Participants
|
5 Participants
n=6 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=2 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=6 Participants
|
|
Race (NIH/OMB)
Asian
|
1 Participants
n=2 Participants
|
2 Participants
n=4 Participants
|
3 Participants
n=6 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=2 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=6 Participants
|
|
Race (NIH/OMB)
Black or African American
|
2 Participants
n=2 Participants
|
0 Participants
n=4 Participants
|
2 Participants
n=6 Participants
|
|
Race (NIH/OMB)
White
|
1 Participants
n=2 Participants
|
3 Participants
n=4 Participants
|
4 Participants
n=6 Participants
|
|
Race (NIH/OMB)
More than one race
|
1 Participants
n=2 Participants
|
0 Participants
n=4 Participants
|
1 Participants
n=6 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=2 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=6 Participants
|
|
Region of Enrollment
United States
|
5 Participants
n=2 Participants
|
5 Participants
n=4 Participants
|
10 Participants
n=6 Participants
|
PRIMARY outcome
Timeframe: up to 24 hours after the study was completed by the participantPercentage of kidney that was visualized
Outcome measures
| Measure |
AR Guided
n=5 Participants
Trainees can see experts' gaze through the HoloLens
|
Non-AR Guided
n=5 Participants
Trainees cannot see experts' gaze through the HoloLens. This should be the standard of care control group.
|
|---|---|---|
|
Completeness of Kidney Exploration
|
71 percentage of kidney seen
Standard Deviation 27
|
67 percentage of kidney seen
Standard Deviation 29
|
SECONDARY outcome
Timeframe: up to 24 hours after experiment completed by the participantExtracted from eye-camera recording from the HoloLens 2, total gaze path seen
Outcome measures
| Measure |
AR Guided
n=5 Participants
Trainees can see experts' gaze through the HoloLens
|
Non-AR Guided
n=5 Participants
Trainees cannot see experts' gaze through the HoloLens. This should be the standard of care control group.
|
|---|---|---|
|
Gaze Path of the User While Performing Kidney Exploration
|
3755 cm
Standard Deviation 2773
|
4158 cm
Standard Deviation 2213
|
SECONDARY outcome
Timeframe: up to 24 hours after experiment completed by the participantTime for the stone identification task
Outcome measures
| Measure |
AR Guided
n=5 Participants
Trainees can see experts' gaze through the HoloLens
|
Non-AR Guided
n=5 Participants
Trainees cannot see experts' gaze through the HoloLens. This should be the standard of care control group.
|
|---|---|---|
|
Completion Time
|
185 seconds
Standard Deviation 158
|
205 seconds
Standard Deviation 174
|
SECONDARY outcome
Timeframe: up to 24 hours after experiment completed by the participantNumber of stones seen
Outcome measures
| Measure |
AR Guided
n=5 Participants
Trainees can see experts' gaze through the HoloLens
|
Non-AR Guided
n=5 Participants
Trainees cannot see experts' gaze through the HoloLens. This should be the standard of care control group.
|
|---|---|---|
|
Stone Count
|
23 number of stones
|
16 number of stones
|
Adverse Events
AR Guided
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Non-AR Guided
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place